Intellectual Property News - Secerna LLP

Cell Therapy

In-depth Series: EPO Case Law relating to cell therapies: a summary of 2025

European Industry News News 29/01/2026

Here, we take a closer look at a selection of decisions from 2025 that highlight the recent patentability and procedural issues seen in the field of cell-based therapeutics.

Read more

IMBRUVICA

News, A to Z Feature 30/01/2025

A to Z: Drugs in Highlight: I is for IMBRUVICA®

Secerna Website Images 2025 (4)

Industry news, News 27/01/2025

Unlocking Faster Cancer Treatments: The Power of Project Orbis

Secerna Website Images 2025 (3)

Industry news, News, Team news 24/01/2025

Secerna Expands Life Sciences Team with the Addition of Trainee Patent Attorney

HERCEPTIN

News, A to Z Feature 23/01/2025

A to Z: Drugs in Highlight: H is for HERCEPTIN®

EPO 2021

European, News 21/01/2025

Added Matter Objections at the European Patent Office (EPO)

Secerna Website Images 2025

Industry news, News 20/01/2025

Thatchers vs Aldi: A Victory in the Battle Against Cloudy Lemon Cider Dupe

Generative AI

Industry news, News 17/01/2025

USPTO Announces AI Strategy to Empower Responsible Innovation

GILENYA

News, A to Z Feature 16/01/2025

A to Z: Drugs in Highlight: G is for GILENYA®

Jason Boakes And Sam Turton Secerna LLP (2)

News, Team news, Careers 14/01/2025

Secerna Strengthens Team with Addition of Trade Mark Attorney

9 10 11 12 13 14 15 16 17 18 19